What We Saw at the Dermatology Drug Development Summit in 2025?
The Dermatology Drug Development Summit is the definitive industry-led forum that unites a driven community trailblazing innovative drug discovery research and clinical strategy to collectively improve the long-term quality of life for patients with immuno-inflammatory disease.
Recognizing how disease heterogeneity and biomarker discovery is triggering a new wave of novel drug discovery efforts while clinical pipelines saw increasing competition, staying ahead of the curve to develop differentiated candidates for novel inflammatory targets had never been more important.
Who Did You Meet?
The 9th Dermatology Drug Development meeting united 120+ key voices in pharma, biotech, investment, across discovery biology, preclinical R&D, early development, clin dev, med affairs, and pipeline advancement.
From C-Level executives to senior scientists, came together in November 2025 to hear the latest unpublished data, hear heated panel discussion, structured group discussions and deep-dive workshops you won’t find anywhere else.